Dr. Nalini has over 26 years of experience to her credit.
Dr. Nalini is an academician with extensive teaching experience and has also been a speaker in many national and international conferences and symposia.
Dr. Nalini handles up to 400 cases per year.
Dr. Nalini has significant teaching experience and has also been a speaker at various conferences and symposia.
She is very active in clinical trials and has been a principal investigator for over 25 multi-centric trials.
She is a member of the Indian Medical Association (IMA), Bengaluru Oncology Group and the Indian Society of Oncology (ISO).
Acute interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer after crizotinib therapy. Oxford medical case reports, 2014(1), 11-12. 2014.
Paediatric Primary Spinal Glioblastoma Multiforme In Association With Congenital Malformations: A Case Report. Journal of Cancer Research & Therapeutics, 13. 2017.
An Unusual Presentation of CNS Germ Cell Tumour: Case Report. Journal of Cancer Research & Therapeutics, 13. 2017.
Hypomethylating agents use in acute myeloid leukaemia: A single-centre experience. 2020. Indian Journal of Medical and Paediatric Oncology, 41(02), 202-208.2020.
Management of abemaciclib associated diarrhoea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study. In Cancer Research. AMER ASSOC CANCER RESEARCH. 2021.
Unusual aetiology of secondary thyrotoxicosis and its presentation. South Asian journal of cancer, 2015, 4(01), 046-047. 2015.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.